Amarin Corporation plc

Amarin Corporation plcverified

AMRN

Price:

$16.46

Market Cap:

$340.44M

Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the...[Read more]

Industry

Biotechnology

IPO Date

1993-04-01

Stock Exchange

NASDAQ

Ticker

AMRN

The Enterprise Value as of December 2025 (TTM) for Amarin Corporation plc (AMRN) is 224.37M

According to Amarin Corporation plc’s latest financial reports and current stock price. The company's current Enterprise Value is 224.37M. This represents a change of -94.79% compared to the average of 4.30B of the last 4 quarters.

Amarin Corporation plc (AMRN) Historical Enterprise Value (quarterly & annually)

How has AMRN Enterprise Value performed in the past?

The mean historical Enterprise Value of Amarin Corporation plc over the last ten years is 35.03B. The current 224.37M Enterprise Value has changed -35.94% with respect to the historical average. Over the past ten years (40 quarters), AMRN's Enterprise Value was at its highest in in the December 2019 quarter at 153.42B. The Enterprise Value was at its lowest in in the March 2025 quarter at 73.63M.

Quarterly (TTM)
Annual

Average

35.03B

Median

17.37B

Minimum

3.87B

Maximum

146.30B

Amarin Corporation plc (AMRN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Amarin Corporation plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 271.12%

Maximum Annual Enterprise Value = 146.30B

Minimum Annual Increase = -76.06%

Minimum Annual Enterprise Value = 3.87B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20243.87B-41.91%
20236.67B-29.83%
20229.50B-64.12%
202126.48B-24.41%
202035.03B-76.06%
2019146.30B81.20%
201880.74B271.12%
201721.76B67.45%
201612.99B87.57%
20156.93B97.21%

Amarin Corporation plc (AMRN) Average Enterprise Value

How has AMRN Enterprise Value performed in the past?

The current Enterprise Value of Amarin Corporation plc (AMRN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

6.68B

5-year avg

16.31B

10-year avg

35.03B

Amarin Corporation plc (AMRN) Enterprise Value vs. Peers

How is AMRN’s Enterprise Value compared to its peers?

Amarin Corporation plc’s Enterprise Value is less than Silence Therapeutics plc (254.57M), less than Alto Neuroscience, Inc. (272.30M), greater than AC Immune S.A. (211.81M), less than Cellectis S.A. (392.08M), less than Larimar Therapeutics, Inc. (299.00M), greater than Korro Bio, Inc. (74.88M), less than DBV Technologies S.A. (361.49M), less than enGene Holdings Inc. (396.46M), less than Altimmune, Inc. (407.41M), less than Lyell Immunopharma, Inc. (488.00M),

CompanyEnterprise ValueMarket cap
254.57M$336.78M
272.30M$415.67M
211.81M$289.73M
392.08M$484.47M
299.00M$314.97M
74.88M$63.86M
361.49M$312.18M
396.46M$420.82M
407.41M$468.65M
488.00M$540.20M

Build a custom stock screener for Amarin Corporation plc (AMRN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Amarin Corporation plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Amarin Corporation plc (AMRN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Amarin Corporation plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Amarin Corporation plc's Enterprise Value?

What is the highest Enterprise Value for Amarin Corporation plc (AMRN)?

What is the 3-year average Enterprise Value for Amarin Corporation plc (AMRN)?

What is the 5-year average Enterprise Value for Amarin Corporation plc (AMRN)?

How does the current Enterprise Value for Amarin Corporation plc (AMRN) compare to its historical average?